Anti-Human ENG Recombinant Antibody (TAB-013ML)

Recombinant monoclonal antibody to ENG. It is a human monoclonal antibody that can be potentially used in the treatment of Hepatocellular Carcinoma, Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Adult Solid Tumor, Advanced Soft Tissue Sarcoma, Metastatic Breast Cancer, Solid Tumors, Lung Cancer, Hepatoma, Liver Neoplasms, AdenomaLiver Cell, Carcinoma Hepatocellular, Liver Neoplasms Experimental, Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Neoplasm, Choriocarcinoma. is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.

Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.

Key Features / Benefits

• productname: Anti-Human ENG Recombinant Antibody (TAB-013ML)
• abbr: Anti-ENG Antibody (TAB-013ML)
• Target: ENG
• Host Animal: Human
• Specificity: Human ENG
• Immunogen: The details of the immunogen for this antibody are not available.

Relevant Applications

• ELISA
• IHC
• FC
• IP
• IF
• Inhib
• FuncS
• WB